Atlas Trials

A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib

Clinical trial NCT01324596 · COMPLETED

Trial details

NCT number
NCT01324596
Sponsor
University Hospital Southampton NHS Foundation Trust
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lymphoma, Large B-Cell, Diffuse
Start date
2011-04-01
Primary completion
2015-04-01
Enrollment
1132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.